Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

Okay, Mufide; Aslan, Tuncay; Ozdemir, Evren; ÜNER, AYŞEGÜL; Saglam, Arzu; Gungor, Elif; Uysal, Ayse; Aslan, Nevin; Yildizhan, Esra; Agit, Abdullah; Dal, Mehmet; Korkmaz, Serdal; Namdaroglu, Sinem; Sivgin, Serdar; Cagliyan, Gulsum; Demircioğlu, Sinan; BARIŞTA, İBRAHİM; Ozhamam, Esra; VURAL, FİLİZ; Eser, Bulent; Ozet, Gulsum; Yildirim, Rahsan; Dogu, Mehmet; Berber, İLHAMİ; ERKURT, MEHMET; Malkan, Umit; Altuntas, Fevzi; BÜYÜKAŞIK, YAHYA

doi:10.4274/tjh.galenos.2019.2019.0177

Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

Atıf İçin Kopyala

Okay M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 37 Sayı: 2
Basım Tarihi: 2020
Doi Numarası: 10.4274/tjh.galenos.2019.2019.0177
Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.84-90
Anahtar Kelimeler: Low-grade lymphoma, Hepatitis B virus, Hepatitis C virus, Risk factors, VILLOUS LYMPHOCYTES, CLINICAL CHARACTERISTICS, CELL LYMPHOMA, RISK-FACTORS, INFECTIONS, REVISION, PATIENT, SERIES, MODEL
İnönü Üniversitesi Adresli: Evet

Özet

Objective: Chronic antigenic stimulation is frequently blamed in the pathogenesis of extranodal marginal zone lymphomas including splenic marginal zone lymphoma (SMZL). Chronic hepatitis C is frequently observed in SMZL patients in some geographical regions. However, these reports are largely from North America and Europe, and data from other countries are insufficient. In this multicenter study we aimed to identify the clinical characteristics of SMZL patients in Turkey, including viral hepatitis status and treatment details.